Colorectal, Cancer Clinical Trials in Yokohama, Kanagawa
2 recruitingYokohama, Kanagawa, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Colorectal, Cancer
AbbVie140 enrolled41 locationsNCT07023289
Recruiting
Phase 1Phase 2
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Colorectal, CancerBiliary Tract CancerPancreatic Ductal Adenocarcinoma
Merck Sharp & Dohme LLC220 enrolled55 locationsNCT06428409